NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
Positive Psychology Intervention for Hematopoietic Stem Cell Transplantation Survivors
Positive Psychology Intervention for Hematopoietic Stem Cell Transplantation Survivors
RecruitingNA
Sponsor: Brigham and Women's Hospital
Conditions: Hematopoietic Stem Cell Transplant
Interventions: PATH
Countries: United States
This randomized clinical trial is evaluating the impact of a positive psychology intervention (PATH) on anxiety symptoms, depression symptoms, and quality of life in survivors of hematopoietic stem cell transplant (HSCT) compared to usual care.
Eligibility overview
Sex: ALL
Age: 18 Years to —
Healthy volunteers: No
Study type: INTERVENTIONAL
Eligibility criteria
Inclusion Criteria: * Adult patients (aged 18 years and older) undergoing allogeneic HSCT and are approaching 100-days post-HSCT * Ability to speak, read, and respond to questions in English or Spanish to complete study procedures * Access to a basic telephone Exclusion Criteria: * Patients who underwent allogeneic HSCT for benign hematologic conditions * Patients with severe psychiatric or cognitive conditions, such as dementia, determined by their transplant oncologist to make them unable to provide informed consent or comply with study procedures
Locations (3)
- Tampa, Florida, United States
- Boston, Massachusetts, United States
- Durham, North Carolina, United States